Justin A Renz - Net Worth and Insider Trading

Justin A Renz Net Worth

The estimated net worth of Justin A Renz is at least $2 Million dollars as of 2024-12-14. Justin A Renz is the CFO of Ardelyx Inc and owns about 291,139 shares of Ardelyx Inc (ARDX) stock worth over $2 Million. Justin A Renz is also the EVP, CFO & Treasurer of Karyopharm Therapeutics Inc and owns about 19,173 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $13,421. Details can be seen in Justin A Renz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Justin A Renz has not made any transactions after 2024-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Justin A Renz

To

Justin A Renz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Justin A Renz owns 3 companies in total, including Ardelyx Inc (ARDX) , Karyopharm Therapeutics Inc (KPTI) , and EPIRUS Biopharmaceuticals Inc (EPRSQ) .

Click here to see the complete history of Justin A Renz’s form 4 insider trades.

Insider Ownership Summary of Justin A Renz

Ticker Comapny Transaction Date Type of Owner
ARDX Ardelyx Inc 2024-11-20 Chief Financial Officer
KPTI Karyopharm Therapeutics Inc 2016-11-09 EVP & Chief Financial Officer
EPRSQ EPIRUS Biopharmaceuticals Inc 2014-02-10 EVP & CFO & Treasurer

Justin A Renz Latest Holdings Summary

Justin A Renz currently owns a total of 2 stocks. Among these stocks, Justin A Renz owns 291,139 shares of Ardelyx Inc (ARDX) as of November 20, 2024, with a value of $2 Million and a weighting of 99.12%. Justin A Renz also owns 19,173 shares of Karyopharm Therapeutics Inc (KPTI) as of November 9, 2016, with a value of $13,421 and a weighting of 0.88%.

Latest Holdings of Justin A Renz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARDX Ardelyx Inc 2024-11-20 291,139 5.22 1,519,746
KPTI Karyopharm Therapeutics Inc 2016-11-09 19,173 0.70 13,421

Holding Weightings of Justin A Renz


Justin A Renz Form 4 Trading Tracker

According to the SEC Form 4 filings, Justin A Renz has made a total of 20 transactions in Ardelyx Inc (ARDX) over the past 5 years, including 1 buys and 19 sells. The most-recent trade in Ardelyx Inc is the sale of 5,260 shares on November 20, 2024, which brought Justin A Renz around $25,195.

According to the SEC Form 4 filings, Justin A Renz has made a total of 0 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 4,342 shares on November 9, 2016, which brought Justin A Renz around $35,561.

Insider Trading History of Justin A Renz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Justin A Renz Trading Performance

GuruFocus tracks the stock performance after each of Justin A Renz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Justin A Renz is 34.93%. GuruFocus also compares Justin A Renz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Justin A Renz within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Justin A Renz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Justin A Renz

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.04 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.71 LIMIT LIMIT LIMIT LIMIT LIMIT

Justin A Renz Ownership Network

Ownership Network List of Justin A Renz

No Data

Ownership Network Relation of Justin A Renz

Insider Network Chart

Justin A Renz Owned Company Details

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Justin A Renz is the Chief Financial Officer of Ardelyx Inc. Other key executives at Ardelyx Inc include director & President & CEO Michael Raab , Chief Development Officer David P. Rosenbaum , and Chief Medical Officer Laura A Williams .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Justin A Renz made 7 insider transaction in Ardelyx Inc (ARDX) with a net sale of 251,814. Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 397,693 shares made by Michael Raab , a net sale of 304,930 shares made by David P. Rosenbaum , and a net sale of 495,440 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 255,927 shares of Ardelyx Inc (ARDX) in total and bought 215,868 shares, with a net sale of 40,059 shares. During the past 18 months, 2,053,731 shares of Ardelyx Inc (ARDX) were sold and 215,868 shares were bought by its insiders, resulting in a net sale of 1,837,863 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ardelyx Inc Insider Transactions

No Available Data

Justin A Renz Mailing Address

Above is the net worth, insider trading, and ownership report for Justin A Renz. You might contact Justin A Renz via mailing address: C/o Karyopharm Therapeutics Inc., 85 Wells Avenue, Second Floor, Newton Ma 02459.